Skip to main content

Advertisement

Log in

Immunological mechanisms in glaucoma

  • Review
  • Published:
Seminars in Immunopathology Aims and scope Submit manuscript

Abstract

Glaucoma is one of the most frequent causes of blindness worldwide. The elevated intraocular pressure does not explain glaucoma in all patients but can be considered as a risk factor of the disease. There are some evidences that autoimmune mechanisms may be involved in this disorder. This review attempts to demonstrate the findings about autoimmune mechanisms in glaucoma patients. Consistent up- and down-regulations in the autoantibody profiles against ocular antigens are present in glaucoma patients. These changes in natural autoimmunity could be found in independent study populations and might be a promising tool for glaucoma detection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Avrameas S (1991) Natural autoantibodies: from ‘horror autotoxicus’ to ‘gnothi seauton’. Immunol Today 12:154–159

    PubMed  CAS  Google Scholar 

  2. Erlanger BF (1989) Some thoughts on the structural basis of internal imagery. Immunol Today 10:151–152

    Article  PubMed  CAS  Google Scholar 

  3. Fernandez-Shaw C, Marina A, Cazorla P, Valdivieso F, Vazquez J (1997) Anti-brain spectrin immunoreactivity in Alzheimer’s disease: degradation of spectrin in an animal model of cholinergic degeneration. J Neuroimmunol 77:91–98

    Article  PubMed  CAS  Google Scholar 

  4. Fisher J, Levkovitch-Verbin H, Schori H, Yoles E, Butovsky O, Kaye JF, Ben-Nun A, Schwartz M (2001) Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. J Neurosci 21:136–142

    PubMed  CAS  Google Scholar 

  5. George J, Gilburd B, Shoenfeld Y (1997) The emerging concept of pathogenic natural autoantibodies. Hum Antibodies 8:70–75

    PubMed  CAS  Google Scholar 

  6. Graus YM, De Baets MH (1993) Myasthenia gravis: an autoimmune response against the acetylcholine receptor. Immunol Res 12:78–100

    Article  PubMed  CAS  Google Scholar 

  7. Grus FH, Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Wax MB (2006) Serum autoantibodies to {alpha}-fodrin are present in glaucoma patients from Germany and the United States. Invest Ophthalmol Vis Sci 47:968–976

    Article  PubMed  Google Scholar 

  8. Grus FH, Joachim SC, Hoffmann EM, Pfeiffer N (2004) Complex autoantibody repertoires in patients with glaucoma. Mol Vis 10:132–137

    PubMed  CAS  Google Scholar 

  9. Grus FH, Joachim SC, Pfeiffer N (2003) Analysis of complex autoantibody repertoires by surface-enhanced laser desorption/ionization-time of flight mass spectrometry. Proteomics 3:957–961

    Article  PubMed  CAS  Google Scholar 

  10. Hughes BW, Moro De Casillas ML, Kaminski HJ (2004) Pathophysiology of myasthenia gravis. Semin Neurol 24:21–30

    Article  PubMed  Google Scholar 

  11. Ikeda Y, Maruyama I, Nakazawa M, Ohguro H (2002) Clinical significance of serum antibody against neuron-specific enolase in glaucoma patients. Jpn J Ophthalmol 46:13–17

    Article  PubMed  CAS  Google Scholar 

  12. Janicke RU, Ng P, Sprengart ML, Porter AG (1998) Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J Biol Chem 273:15540–15545

    Article  PubMed  CAS  Google Scholar 

  13. Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Grus FH (2007) Antibodies to alpha B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor. Curr Eye Res 32:501–509

    Article  PubMed  CAS  Google Scholar 

  14. Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Grus FH (2007) Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with “wet” age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 245:619–626

    Article  PubMed  CAS  Google Scholar 

  15. Joachim SC, Grus FH, Pfeiffer N (2003) Analysis of autoantibody repertoires in sera of patients with glaucoma. Eur J Ophthalmol 13:752–758

    PubMed  CAS  Google Scholar 

  16. Joachim SC, Kraft D, Pfeiffer N, Wax MB, Grus FH (2006) Antibody profile analysis via western blot and protein-chip methods in a retinal ganglion cell degeneration animal model. From Genome to Proteome Meeting

  17. Joachim SC, Pfeiffer N, Grus FH (2005) Autoantibodies in patients with glaucoma: a comparison of IgG serum antibodies against retinal, optic nerve, and optic nerve head antigens. Graefes Arch Clin Exp Ophthalmol 243:817–823

    Article  PubMed  CAS  Google Scholar 

  18. Joachim SC, Reichelt J, Pfeiffer N, Grus FH (2006) Autoantibody profiles against human retina in sera of glaucoma patients. DOG Meeting

  19. Joachim SC, Wuenschig D, Pfeiffer N, Grus FH (2007) IgG antibody patterns in aqueous humor of patients with primary open angle glaucoma and pseudoexfoliation glaucoma. Mol Vis 13:1573–1579

    PubMed  CAS  Google Scholar 

  20. Johnson EM Jr., Gorin PD, Osborne PA, Rydel RE, Pearson J (1982) Effects of autoimmune NGF deprivation in the adult rabbit and offspring. Brain Res 240:131–140

    Article  PubMed  CAS  Google Scholar 

  21. Kremmer S, Kreuzfelder E, Klein R, Bontke N, Henneberg-Quester KB, Steuhl KP, Grosse-Wilde H (2001) Antiphosphatidylserine antibodies are elevated in normal tension glaucoma. Clin Exp Immunol 125:211–215

    Article  PubMed  CAS  Google Scholar 

  22. Kulberg AY (1999) Immunoglobulins and Antibodies. Russ J Immunol 4:241–242

    PubMed  Google Scholar 

  23. Li WH, Zhao J, Li HY, Liu H, Li AL, Wang HX, Wang J, He K, Liang B, Yu M, Shen BF, Zhang XM (2006) Proteomics-based identification of autoantibodies in the sera of healthy Chinese individuals from Beijing. Proteomics 6:4781–4789

    Article  PubMed  CAS  Google Scholar 

  24. Maruyama I, Ohguro H, Ikeda Y (2000) Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients. Invest Ophthalmol Vis Sci 41:1657–1665

    PubMed  CAS  Google Scholar 

  25. McKinnon SJ (2003) Glaucoma: ocular Alzheimer’s disease? Front Biosci 8:s1140–1156

    Article  PubMed  CAS  Google Scholar 

  26. Nobrega A, Haury M, Grandien A, Malanchere E, Sundblad A, Coutinho A (1993) Global analysis of antibody repertoires. II. Evidence for specificity, self-selection and the immunological “homunculus” of antibodies in normal serum. Eur J Immunol 23:2851–2859

    Article  PubMed  CAS  Google Scholar 

  27. Poletaev A, Osipenko L (2003) General network of natural autoantibodies as immunological homunculus (Immunculus). Autoimmun Rev 2:264–271

    Article  PubMed  CAS  Google Scholar 

  28. Poletaev AB, Abrosimova AA, Sokolov MA, Gekht AB, Alferova VV, Gusev EI, Nikolaeva TY, Selmi C (2004) Dialectics and implications of natural neurotropic autoantibodies in neurological disease and rehabilitation. Clin Dev Immunol 11:151–156

    Article  PubMed  CAS  Google Scholar 

  29. Poletaev AB, Gnedenko BB, Makarova AA, Krasnopolsky VI, Budykina TS, Petrukhin VA, Morozov SG (2000) Possible mechanisms of diabetic fetopathy. Hum Antibodies 9:189–197

    PubMed  CAS  Google Scholar 

  30. Poletaev AB, Morozov SG, Gnedenko BB, Zlunikin VM, Korzhenevskey DA (2000) Serum anti-S100b, anti-GFAP and anti-NGF autoantibodies of IgG class in healthy persons and patients with mental and neurological disorders. Autoimmunity 32:33–38

    Article  PubMed  CAS  Google Scholar 

  31. Quigley HA (1996) Number of people with glaucoma worldwide. Br J Ophthalmol 80:389–393

    Article  PubMed  CAS  Google Scholar 

  32. Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90:262–267

    Article  PubMed  CAS  Google Scholar 

  33. Reichelt J, Joachim SC, Pfeiffer N, Grus FH (2006) Analysis of autoantibodies against human retinal antigens in sera of patients with glaucoma and ocular hypertension. Graefes Arch Clin Exp Ophthalmol DOI 10.1007/s00417-007-0737-8

  34. Scofield RH (2004) Autoantibodies as predictors of disease. Lancet 363:1544–1546

    Article  PubMed  CAS  Google Scholar 

  35. Sihag RK, Cataldo AM (1996) Brain beta-spectrin is a component of senile plaques in Alzheimer’s disease. Brain Res 743:249–257

    Article  PubMed  CAS  Google Scholar 

  36. Singer HS, Loiselle CR, Lee O, Garvey MA, Grus FH (2003) Anti-basal ganglia antibody abnormalities in Sydenham chorea. J Neuroimmunol 136:154–161

    Article  PubMed  CAS  Google Scholar 

  37. Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt J, Singh K (1991) Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 109:1090–1095

    PubMed  CAS  Google Scholar 

  38. Tahzib NG, Ransom NL, Reitsamer HA, McKinnon SJ (2004) Alpha-fodrin is cleaved by caspase-3 in a chronic ocular hypertensive (COH) rat model of glaucoma. Brain Res Bull 62:491–495

    Article  PubMed  CAS  Google Scholar 

  39. Terzoglou AG, Routsias JG, Avrameas S, Moutsopoulos HM, Tzioufas AG (2006) Preferential recognition of the phosphorylated major linear B-cell epitope of La/SSB 349–368 aa by anti-La/SSB autoantibodies from patients with systemic autoimmune diseases. Clin Exp Immunol 144:432–439

    Article  PubMed  CAS  Google Scholar 

  40. Tezel G, Wax MB (2004) The immune system and glaucoma. Curr Opin Ophthalmol 15:80–84

    Article  PubMed  Google Scholar 

  41. Tezel G, Wax MB (2007) Glaucoma. Chem Immunol Allergy 92:221–227

    PubMed  CAS  Google Scholar 

  42. Tezel G, Edward DP, Wax MB (1999) Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma. Arch Ophthalmol 117:917–924

    PubMed  CAS  Google Scholar 

  43. Tezel G, Hernandez R, Wax MB (2000) Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes. Arch Ophthalmol 118:511–518

    PubMed  CAS  Google Scholar 

  44. Tezel G, Luo C, Yang X (2007) Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Invest Ophthalmol Vis Sci 48:1201–1211

    Article  PubMed  Google Scholar 

  45. Tezel G, Seigel GM, Wax MB (1998) Autoantibodies to small heat shock proteins in glaucoma. Invest Ophthalmol Vis Sci 39:2277–2287

    PubMed  CAS  Google Scholar 

  46. Tezel G, Yang X, Cai J (2005) Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma. Invest Ophthalmol Vis Sci 46:3177–3187

    Article  PubMed  Google Scholar 

  47. Tezel G, Yang X, Luo C, Peng Y, Sun SL, Sun D (2007) Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia. Invest Ophthalmol Vis Sci 48:705–714

    Article  PubMed  Google Scholar 

  48. Vazquez J, Fernandez-Shaw C, Marina A, Haas C, Cacabelos R, Valdivieso F (1996) Antibodies to human brain spectrin in Alzheimer’s disease. J Neuroimmunol 68:39–44

    Article  PubMed  CAS  Google Scholar 

  49. Vincent A, McConville J, Farrugia ME, Newsom-Davis J (2004) Seronegative myasthenia gravis. Semin Neurol 24:125–133

    Article  PubMed  Google Scholar 

  50. Wax MB, Tezel G (2002) Neurobiology of glaucomatous optic neuropathy: diverse cellular events in neurodegeneration and neuroprotection. Mol Neurobiol 26:45–55

    Article  PubMed  CAS  Google Scholar 

  51. Wax MB, Barrett DA, Pestronk A (1994) Increased incidence of paraproteinemia and autoantibodies in patients with normal-pressure glaucoma. Am J Ophthalmol 117:561–568

    PubMed  CAS  Google Scholar 

  52. Wax MB, Tezel G, Saito I, Gupta RS, Harley JB, Li Z, Romano C (1998) Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma. Am J Ophthalmol 125:145–157

    Article  PubMed  CAS  Google Scholar 

  53. Weinreb RN, Khaw PT (2004) Primary open-angle glaucoma. Lancet 363:1711–1720

    Article  PubMed  Google Scholar 

  54. Yang J, Tezel G, Patil RV, Romano C, Wax MB (2001) Serum autoantibody against glutathione S-transferase in patients with glaucoma. Invest Ophthalmol Vis Sci 42:1273–1276

    PubMed  CAS  Google Scholar 

  55. Zimmermann CW, Eblen F (1993) Repertoires of autoantibodies against homologous eye muscle in ocular and generalized myasthenia gravis differ. Clin Investig 71:445–451

    Article  PubMed  CAS  Google Scholar 

  56. Zimmermann CW, Weiss G (1987) Antibodies not directed against the acetylcholine receptor in myasthenia gravis. An immunoblot study. J Neuroimmunol 16:225–236

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. Grus.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grus, F., Sun, D. Immunological mechanisms in glaucoma. Semin Immunopathol 30, 121–126 (2008). https://doi.org/10.1007/s00281-008-0105-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00281-008-0105-8

Keywords

Navigation